🇺🇸 FDA
Pipeline program

Inhaled Placebo

2025VAP

Unknown small_molecule active

Quick answer

Inhaled Placebo for Ventilator-Associated Pneumonia (VAP) is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Ventilator-Associated Pneumonia (VAP)
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials